According to Nova One Advisor, the global mRNA synthesis & manufacturing market size is calculated at USD 1.58 billion in 2025 and is expected to be hit around USD 1.87 billion by 2034, growing at a ...

Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

TriLink’s CleanCap technology produces optimal 5′ cap structures with over 95% efficiency, creating a co-transcriptional capping solution that dramatically improves mRNA yield and process time when ...

More than 80 million Americans are diagnosed with some type of allergy. Allergies can be caused by the environment, pets, food, and medication, with symptoms ranging from an annoying runny nose to ...